ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 17.04.
| Share Price | ₹1,790.9 | Nov 10,2025 |
| Market Cap | ₹20,505.8 Cr | |
| Sales-TTM | ₹1,203.2 Cr | TTM-Standalone Results |
| Price/Sales | 17.04x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,505.8 Cr] as on Nov 10,2025
(/) Sales [ ₹1,203.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 17.04x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '17.04 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 5.13x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 15.39x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA | 1,203.2 | 17.04 | 20,505.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.41 | 407,287.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.71 | 177,657.0 |
| CIPLA LTD | 28,349.6 | 4.31 | 122,276.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.55 | 129,202.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.92 | 100,024.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.80 | 92,301.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.89 | 95,295.4 |
| LUPIN LTD | 24,750.7 | 3.67 | 90,774.6 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.06 | 66,969.3 |
| ABBOTT INDIA LTD | 6,714.4 | 9.33 | 62,678.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.06x |
| Max industry PS | 17.71x |
| Median industry PS | 6.80x |
| Average industry PS | 7.79x |
You may also like the below Video Courses